MGUS polyneuropathy: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 32: | Line 32: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 18:41, 18 March 2025
MGUS Polyneuropathy is a medical condition that is associated with Monoclonal Gammopathy of Undetermined Significance (MGUS). It is characterized by damage to the peripheral nerves, which can lead to symptoms such as numbness, tingling, and weakness in the limbs.
Symptoms[edit]
The symptoms of MGUS Polyneuropathy can vary widely, but often include:
- Numbness and tingling in the limbs
- Weakness
- Pain
- Muscle atrophy
- Impaired balance
Causes[edit]
MGUS Polyneuropathy is caused by the presence of a monoclonal protein in the blood, which is produced by abnormal plasma cells. This protein can damage the peripheral nerves, leading to the symptoms of the condition.
Diagnosis[edit]
The diagnosis of MGUS Polyneuropathy is typically made through a combination of clinical examination, blood tests, and nerve conduction studies. A biopsy of the affected nerve may also be performed in some cases.
Treatment[edit]
The treatment of MGUS Polyneuropathy is primarily focused on managing the symptoms of the condition. This can include medications to control pain and other symptoms, physical therapy to improve strength and balance, and in some cases, treatment of the underlying MGUS.
See also[edit]
References[edit]
<references />


